The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Alternate Stoichiometries of α4β2 Nicotinic Acetylcholine Receptors
Abstract
Two functional types of nicotinic acetylcholine receptors (nAChRs) are expressed when human embryonic kidney cells are permanently transfected with equal amounts of human alpha4 and beta2 subunit cDNAs. Most (82%) of these nAChRs exhibit an EC(50) of 74 +/- 6 microM for ACh, a much lower sensitivity than the remaining fraction (EC(50) of 0.7 +/- 0.4 microM) or than expected from expression of equal amounts of alpha4 and beta2 mRNAs in Xenopus laevis oocytes. We have found three conditions that can increase the number of nAChRs with high sensitivity to activation. These are: 1) transient transfection with additional beta2 subunits, 2) overnight incubation in nicotine, or 3) overnight culture at 29 degrees C. Using metabolic labeling with [(35)S]methionine to measure subunit stoichiometry, we found that the majority of nAChRs had a stoichiometry of (alpha4)(3)(beta2)(2). Overnight treatment with nicotine increased the number of nAChRs and increased the proportion of the (alpha4)(2)(beta2)(3) stoichiometry. Alternate alpha4beta2 nAChR stoichiometries with distinct functional properties raise the possibility for an interesting mode of synaptic regulation for nicotinic signaling in the mammalian brain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Data from such favorable systems show that nicotine enhances the assembly of functional nAChRs containing the α4 and β2 subunits and also causes the preferential assembly of receptors with (α4)2(β2)3 stoichiometry (Buisson and Bertrand, 2001; Nelson et al., 2003; Kuryatov et al., 2005; Sallette et al., 2005; Vallejo et al., 2005; Son et al., 2009).”
From Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning (2011) · cites this paper as Nelson et al., 2003
In the citing paper
“Data from such favorable systems show that nicotine enhances the assembly of functional nAChRs containing the α4 and β2 subunits and also causes the preferential assembly of receptors with (α4)2(β2)3 stoichiometry (Buisson and Bertrand, 2001; Nelson et al., 2003; Kuryatov et al., 2005; Sallette et al., 2005; Vallejo et al., 2005; Son et al., 2009).”
From Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning (2011) · cites this paper as Nelson et al., 2003
In the citing paper
“Because nicotine is thought to increase the assembly of receptors with a (α4)2(β2)3 stoichiometry (Nelson et al., 2003; Son et al., 2009)”
From Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning (2011) · cites this paper as Nelson et al., 2003
In the citing paper
“In fact, our experiments and previous data (Buisson and Bertrand, 2001; Nelson et al., 2003; Kuryatov et al., 2005; Sallette et al., 2005; Vallejo et al., 2005; Son et al., 2009) suggest a shift from approximately equal contributions of the two stoichiometries in nicotine-naive cells to ∼100% (α4)2(β2)3 after chronic nicotine exposure.”
From Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning (2011) · cites this paper as Nelson et al., 2003
In the citing paper
“These data correspond with previous results based on glycosylation and molecular weight measures, showing that up-regulation is initiated in the ER (Nelson et al., 2003; Kuryatov et al., 2005; Sallette et al., 2005).”
From Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning (2011) · cites this paper as Nelson et al., 2003
In the citing paper
“The thermodynamic driving force for this stoichiometry shift is presumably the tighter binding of nicotine to the (α4)2(β2)3 stoichiometry (Nelson et al., 2003).”
From Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning (2011) · cites this paper as Nelson et al., 2003
In the citing paper
“Several studies suggest that the two forms differ in subunit composition: the high- and low-sensitivity forms would consist of the (α4)2(β2)3 and (α4)3(β2)2 pentamers, respectively (74–76).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [76]
Citations
Cites
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308
An adaptive coding model of neural function in prefrontal cortex
Sanes, J., & Lichtman, J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35097557 · Cited by 1,056
An adaptive coding model of neural function in prefrontal cortex
Duncan, J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35097575 · Cited by 874
An adaptive coding model of neural function in prefrontal cortex
Duncan, J. (2001) · UCL Discovery (University College London) · Cited by 738
Toward a structural basis for the function of nicotinic acetylcholine receptors and their cousins
Karlin, A., & Akabas, M. H. (1995) · Neuron · doi:10.1016/0896-6273(95)90004-7 · Cited by 622
Evidence that Tobacco Smoking Increases the Density of (−)‐[3H]Nicotine Binding Sites in Human Brain
Benwell, M. E. M., Balfour, D. J. K., & Anderson, J. M. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb10600.x · Cited by 551
Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment
Marks, M., Pauly, Jr., Gross, S., Deneris, E., Hermans-Borgmeyer, I., Heinemann, S., & Collins, A. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-07-02765.1992 · Cited by 551
Reduced antinociception in mice lacking neuronal nicotinic receptor subunits
Marubio, L. M., Jiménez, M. D. M. A., Cordero‐Erausquin, M., Léna, C., Novère, N. G. L., d’Exaerde, A. D. K., Huchet, M., Damaj, M. I., & Changeux, J. (1999) · Nature · doi:10.1038/19756 · Cited by 538
Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor
Cooper, E., Couturier, S., & Ballivet, M. (1991) · Nature · doi:10.1038/350235a0 · Cited by 470
Flagged first, then by citations
Cited by
Sorted by citations
Mammalian nicotinic acetylcholine receptors: from structure to function
Albuquerque, E. X., Pereira, E. F. R., Alkondon, M., & Rogers, S. W. (2009) · Physiological Reviews · doi:10.1152/physrev.00015.2008 · Cited by 1,724
Neuronal nicotinic receptors: from structure to pathology
Gotti, C., & Clementi, F. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.09.006 · Cited by 970
Brain nicotinic acetylcholine receptors: native subtypes and their relevance
Gotti, C., Zoli, M., & Clementi, F. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.004 · Cited by 882
Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system
Taly, A., Corringer, P., Guédin, D., Lestage, P. J., & Changeux, J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2927 · Cited by 743
Chromosome 21 and Down syndrome: from genomics to pathophysiology
Antonarakis, S. E., Lyle, R., Dermitzakis, E. T., Reymond, A., & Deutsch, S. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1448 · Cited by 703
Jensen, A. A., Frølund, B., Liljefors, T., & Krogsgaard‐Larsen, P. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040219e · Cited by 549
Nicotinic acetylcholine receptors: From basic science to therapeutics
Hurst, R. S., Rollema, H., & Bertrand, D. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.012 · Cited by 543
Structural and functional diversity of native brain neuronal nicotinic receptors
Gotti, C., Clementi, F., Fornari, A., Gaimarri, A., Guiducci, S., Manfredi, I., Moretti, M., Pedrazzi, P., Pucci, L., & Zoli, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.024 · Cited by 469
Diversity of vertebrate nicotinic acetylcholine receptors
Millar, N. S., & Gotti, C. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.041 · Cited by 441
X-ray structure of the human α4β2 nicotinic receptor
Morales-Pérez, C. L., Noviello, C., & Hibbs, R. E. (2016) · Nature · doi:10.1038/nature19785 · Cited by 413
Nicotine binding to brain receptors requires a strong cation–π interaction
Xiu, X., Puskar, N. L., Shanata, J. A. P., Lester, H. A., & Dougherty, D. A. (2009) · Nature · doi:10.1038/nature07768 · Cited by 363
Govind, A. P., Vezina, P., & Green, W. N. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.011 · Cited by 338
Moroni, M., Zwart, R., Sher, E., Cassels, B. K., & Bermúdez, I. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.023044 · Cited by 286
Heterogeneity and complexity of native brain nicotinic receptors
Gotti, C., Moretti, M., Gaimarri, A., Zanardi, A., Clementi, F., & Zoli, M. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.05.023 · Cited by 282
Diversity of native nicotinic receptor subtypes in mammalian brain
Zoli, M., Pistillo, F., & Gotti, C. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.003 · Cited by 277
Nicotine acts as a pharmacological chaperone to up-regulate human α4β2 acetylcholine receptors
Kuryatov, A., Luo, J., Cooper, J., & Lindstrom, J. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012419 · Cited by 275
Self-citationNicotine upregulates its own receptors through enhanced intracellular maturation
Sallette, J., Pons, S., Devillers-Thiery, A., Soudant, M., Prado de Carvalho, L., Changeux, J.-P., & Corringer, P. J. (2005) · Neuron · doi:10.1016/j.neuron.2005.03.029 · Cited by 261
The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum
Grady, S. R., Salminen, O., Laverty, D. C., Whiteaker, P., McIntosh, J. M., Collins, A. C., & Marks, M. J. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.032 · Cited by 252
Exley, R. A., & Cragg, S. J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707510 · Cited by 271
Structural principles of distinct assemblies of the human α4β2 nicotinic receptor
Walsh, R. M., Roh, S., Gharpure, A., Morales-Pérez, C. L., Teng, J., & Hibbs, R. E. (2018) · Nature · doi:10.1038/s41586-018-0081-7 · Cited by 232
Lam, D. C.-L., Girard, L., Ramirez, R. D., Chau, W.-S., Suen, W., Sheridan, S., Tin, V. P., Chung, L., Wong, M. P., Shay, J. W., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4628 · Cited by 221
Chronic Nicotine Exposure Upregulates Nicotinic Receptors by a Novel Mechanism
Vallejo, Y. F. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.5240-04.2005 · Cited by 201
Tapia, L., Kuryatov, A., & Lindstrom, J. M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.030445 · Cited by 196
Self-citationRoles of Accessory Subunits in α4β2* Nicotinic Receptors
Kuryatov, A., Onksen, J., & Lindstrom, J. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.046789 · Cited by 195
Self-citationα6β2* and α4β2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson’s Disease
Quik, M., & Wonnacott, S. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003269 · Cited by 201
Nashmi, R., Dickinson, M. E., McKinney, S., Jareb, M., Labarca, C., Fraser, S. E., & Lester, H. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-37-11554.2003 · Cited by 188
Merging old and new perspectives on nicotinic acetylcholine receptors
Papke, R. L. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.029 · Cited by 183
Levitt, M. D., Abdel-Rehim, M. S., & Furne, J. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3525 · Cited by 177
Human α4β2 Acetylcholine Receptors Formed from Linked Subunits
Zhou, Y., Nelson, M. E., Kuryatov, A., Choi, C., Cooper, J., & Lindstrom, J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-27-09004.2003 · Cited by 174
Self-citationSrinivasan, R., Pantoja, R., Moss, F. J., Mackey, E. D. W., Son, C. D., Miwa, J., & Lester, H. A. (2011) · Journal of General Physiology · doi:10.1085/jgp.201010532 · Cited by 169
Lester, H. A., Xiao, C., Srinivasan, R., Son, C. D., Miwa, J., Pantoja, R., Banghart, M. R., Dougherty, D. A., Goate, A. M., & Wang, J. C. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9090-7 · Cited by 163
Manipulation of Subunit Stoichiometry in Heteromeric Membrane Proteins
Morales-Pérez, C. L., Noviello, C., & Hibbs, R. E. (2016) · Structure · doi:10.1016/j.str.2016.03.004 · Cited by 150
Nguyen, H. N., Rasmussen, B. A., & Perry, D. C. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.056408 · Cited by 148
Assembly and trafficking of nicotinic acetylcholine receptors (Review)
Millar, N. S., & Harkness, P. C. (2008) · Molecular Membrane Biology · doi:10.1080/09687680802035675 · Cited by 143
Unraveling the High- and Low-Sensitivity Agonist Responses of Nicotinic Acetylcholine Receptors
Harpsøe, K., Ahring, P. K., Christensen, J. K., Jensen, M. L., Peters, D., & Balle, T. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1509-11.2011 · Cited by 142
Naturally-expressed nicotinic acetylcholine receptor subtypes
Wu, J., & Lukas, R. J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.067 · Cited by 139
Hendrickson, L. M., Guildford, M. J., & Tapper, A. R. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00029 · Cited by 140
Nicotinic acetylcholine receptors and the ascending dopamine pathways
Livingstone, P. D., & Wonnacott, S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.004 · Cited by 139
Neurobiological Mechanisms of Nicotine Reward and Aversion
Wills, L. P., Ables, J. L., Braunscheidel, K. M., Caligiuri, S. P. B., Elayouby, K. S., Fillinger, C., Ishikawa, M., Moen, J. K., & Kenny, P. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000299 · Cited by 134
Nicotinic acetylcholine receptors: Conventional and unconventional ligands and signaling
Papke, R. L., & Lindstrom, J. M. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108021 · Cited by 128
Self-citationCarbone, A., Moroni, M., Groot-Kormelink, P., & Bermúdez, I. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00104.x · Cited by 123
Mazzaferro, S., Benallegue, N., Carbone, A. L., Gasparri, F., Vijayan, R., Biggin, P., Moroni, M., & Bermúdez, I. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.262014 · Cited by 122
Biogenesis, trafficking and up-regulation of nicotinic ACh receptors
Colombo, S. F., Mazzo, F., Pistillo, F., & Gotti, C. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.06.023 · Cited by 121
Govind, A. P., Walsh, H., & Green, W. N. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5438-11.2012 · Cited by 116
Neuroimmune Communication in Health and Disease
Reardon, C., Murray, K. M., & Lomax, A. E. (2018) · Physiological Reviews · doi:10.1152/physrev.00035.2017 · Cited by 119
Xiao, C., Nashmi, R., McKinney, S. L., Cai, H., McIntosh, J. M., & Lester, H. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2939-09.2009 · Cited by 117
Nicotinic Receptors in Neurodegeneration
Posadas, I., López‐Hernández, B., & Ceña, V. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311030005 · Cited by 116
Zwart, R., Carbone, A. L., Moroni, M., Bermudez, I., Mogg, A. J., Folly, E. A., Broad, L. M., Williams, A. C., Zhang, D., Ding, C., et al. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.045104 · Cited by 111
Moffat, C., Pacheco, J. P. G., Sharp, S., Samson, A. J., Bollan, K. A., Huang, J. T.-J., Buckland, S. T., & Connolly, C. N. (2015) · The FASEB Journal · doi:10.1096/fj.14-267179 · Cited by 109
Molecular and Cellular Mechanisms of Action of Nicotine in the CNS
Barik, J., & Wonnacott, S. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-69248-5_7 · Cited by 112
Nicotine and cannabinoids: parallels, contrasts and interactions
VIVEROS, M., MARCO, E., & FILE, S. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.08.002 · Cited by 106
Linden, D. R., Levitt, M. D., Farrugia, G., & Szurszewski, J. H. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2885 · Cited by 105
Parker, S. L., Fu, Y., McAllen, K., Luo, J., McIntosh, J. M., Lindstrom, J. M., & Sharp, B. M. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.611 · Cited by 105
Self-citationAllosteric modulation of nicotinic acetylcholine receptors.
Chatzidaki, A., & Millar, N. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.028 · Cited by 164
Chatterjee, S., Steensland, P., Simms, J. A., Holgate, J. Y., Coe, J. W., Hurst, R. S., Shaffer, C. L., Lowe, J. A., III, Rollema, H., & Bartlett, S. E. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.191 · Cited by 103
Timmermann, D. B., Sandager‐Nielsen, K., Dyhring, T., Smith, M., Jacobsen, A., Nielsen, E., Grunnet, M., Christensen, J., Peters, D., Kohlhaas, K. L., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01989.x · Cited by 103
Stoichiometry of the α9α10 Nicotinic Cholinergic Receptor
Plazas, P. V., Katz, E., Gómez‐Casati, M. E., Bouzat, C., & Elgoyhen, A. B. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3805-05.2005 · Cited by 103
The role of nicotinic acetylcholine receptors in autosomal dominant nocturnal frontal lobe epilepsy
Becchetti, A., Aracri, P., Meneghini, S., Brusco, S., & Amadeo, A. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00022 · Cited by 107
Inside-out neuropharmacology of nicotinic drugs
Henderson, B. J., & Lester, H. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.01.022 · Cited by 109
Drenan, R. M., Nashmi, R., Imoukhuede, P., Just, H., McKinney, S., & Lester, H. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.039180 · Cited by 100
Khakh, B. S., Fisher, J. A., Nashmi, R., Bowser, D. N., & Lester, H. A. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0561-05.2005 · Cited by 100
Nicotine is Highly Effective at Producing Desensitization of Rat α4β2 Neuronal Nicotinic Receptors
Paradiso, K. G., & Steinbach, J. H. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.053447 · Cited by 103
Hans, M., Wilhelm, M., & Swandulla, D. (2012) · Chemical Senses · doi:10.1093/chemse/bjr128 · Cited by 98
Progress in nicotinic receptor structural biology
Gharpure, A., Noviello, C., & Hibbs, R. E. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108086 · Cited by 103
Houchat, J., Cartereau, A., Mauff, A. L., Taillebois, E., & Thany, S. H. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17093222 · Cited by 92
Regulation of neuronal nicotinic receptor traffic and expression
Gaimarri, A., Moretti, M., Riganti, L., Zanardi, A., Clementi, F., & Gotti, C. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.02.005 · Cited by 89
Li, P., Ann, J., & Akk, G. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22644 · Cited by 88
Corringer, P.-J., Sallette, J., & Changeux, J.-P. (2006) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2005.12.012 · Cited by 86
Gahring, L. C., Persiyanov, K., Dunn, D. M., Weiss, R. B., Meyer, E. L., & Rogers, S. W. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10943 · Cited by 84
TC‐5214 (S‐(+)‐Mecamylamine): A Neuronal Nicotinic Receptor Modulator with Antidepressant Activity
Lippiello, P. M., Beaver, J. S., Gatto, G. J., James, J. W., Green-Jordan, K., Traina, V. M., Xie, J., & Bencherif, M. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00054.x · Cited by 83
Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors
Wang, J., & Lindstrom, J. M. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13745 · Cited by 82
Self-citationMoroni, M., Vijayan, R., Carbone, A. L., Zwart, R., Biggin, P. C., & Bermúdez, I. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1228-08.2008 · Cited by 81
Marks, M. J., Rowell, P. P., Cao, J., Grady, S. R., McCallum, S. E., & Collins, A. C. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.02.009 · Cited by 81
Sallette, J., Bohler, S., Benoit, P., Soudant, M., Pons, S., Le Novère, N., Changeux, J.-P., & Corringer, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308260200 · Cited by 80
Transcription Deregulation at the 15q25 Locus in Association with Lung Adenocarcinoma Risk
Falvella, F. S., Galvan, A., Frullanti, E., Spinola, M., Calabrò, E., Carbone, A., Incarbone, M., Santambrogio, L., Pastorino, U., & Dragani, T. A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2107 · Cited by 82
Papke, R. L., Dwoskin, L. P., Crooks, P. A., Zheng, G., Zhang, Z., McIntosh, J. M., & Stokes, C. R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.03.010 · Cited by 79
Henderson, B. J., Wall, T. R., Henley, B. M., Kim, C. H., Nichols, W. A., Moaddel, R., Xiao, C., & Lester, H. A. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4194-15.2016 · Cited by 79
Functional alterations by a subgroup of neonicotinoid pesticides in human dopaminergic neurons
Loser, D., Hinojosa, M. G., Blum, J. H., Schaefer, J., Brüll, M., Johansson, Y., Suciu, I., Grillberger, K., Danker, T., Möller, C., et al. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03031-1 · Cited by 77
Molgó, J., Marchot, P., Aráoz, R., Benoit, É., Iorga, B. I., Zakarian, A., Taylor, P., Bourne, Y., & Servent, D. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.13995 · Cited by 75
Huang, L. Z., Campos, C., Ly, J., Carroll, F. I., & Quik, M. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.12.032 · Cited by 76
Coe, J. W., Brooks, P. R., Wirtz, M. C., Bashore, C. G., Bianco, K. E., Vetelino, M. G., Arnold, E. P., Lebel, L. A., Fox, C. B., Tingley, F. D., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.08.035 · Cited by 73
Barrera, N. P., Betts, J. F., You, H., Henderson, R. M., Martin, I. L., Dunn, S. M. J., & Edwardson, J. M. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.042481 · Cited by 72
Grishin, A. A., Wang, C.-I. A., Muttenthaler, M., Alewood, P. F., Lewis, R. J., & Adams, D. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.111880 · Cited by 71
Gotti, C., Moretti, M., Zanardi, A., Gaimarri, A., Champtiaux, N., Changeux, J., Whiteaker, P., Marks, M., Clementi, F., & Zoli, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.015925 · Cited by 72
Tsuneki, H., You, Y., Toyooka, N., Kagawa, S., Kobayashi, S., Sasaoka, T., Nemoto, H., Kimura, I., & Dani, J. A. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000729 · Cited by 70
Lamb, P. W., Melton, M. A., & Yakel, J. L. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:27:1:013 · Cited by 70
Billen, B., Spurný, R., Brams, M., van Elk, R., Valera-Kummer, S., Yakel, J. L., Voets, T., Bertrand, D., Smit, A. B., & Ulens, C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116397109 · Cited by 71
Coe, J. W., Vetelino, M. G., Bashore, C. G., Wirtz, M. C., Brooks, P. R., Arnold, E. P., Lebel, L. A., Fox, C. B., Sands, S. B., Davis, T. I., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.04.036 · Cited by 69
Cellular, molecular, and genetic substrates underlying the impact of nicotine on learning
Gould, T. J., & Leach, P. T. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.08.004 · Cited by 72
3B but which 3B? And that's just one of the questions: the heterogeneity of human 5-HT3 receptors
Jensen, A. A., Davies, P. A., Bräuner‐Osborne, H., & Krzywkowski, K. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.06.001 · Cited by 68
Live-Cell Imaging of Single Receptor Composition Using Zero-Mode Waveguide Nanostructures
Richards, C. I., Luong, K., Srinivasan, R., Turner, S. W., Dougherty, D. A., Korlach, J., & Lester, H. A. (2012) · Nano Letters · doi:10.1021/nl301480h · Cited by 68
Gotti, C., Moretti, M., Meinerz, N. M., Clementi, F., Gaimarri, A., Collins, A. C., & Marks, M. J. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.045203 · Cited by 68
Gao, B.-X., Hierl, M., Clarkin, K., Juan, T., Nguyen, H. Q., van der Valk, M., Deng, H. X., Guo, W., Lehto, S. G., Matson, D. J., et al. (2010) · Pain · doi:10.1016/j.pain.2010.01.007 · Cited by 67
Papke, R. L., Wecker, L., & Stitzel, J. A. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.164566 · Cited by 66
Krashia, P., Moroni, M., Broadbent, S. D., Hofmann, G., Kracun, S., Beato, M., Groot‐Kormelink, P. J., & Sivilotti, L. G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013611 · Cited by 66
Nicotine addiction and psychiatric disorders
Kutlu, M. G., Parikh, V., & Gould, T. J. (2015) · International Review of Neurobiology · doi:10.1016/bs.irn.2015.08.004 · Cited by 65
Kouvatsos, N., Giastas, P., Chroni-Tzartou, D., Poulopoulou, C., & Tzartos, S. J. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602619113 · Cited by 65
Cognitive Deficits in Schizophrenia: Focus on Neuronal Nicotinic Acetylcholine Receptors and Smoking
Ochoa, E. L. M., & Lasalde‐Dominicci, J. A. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9149-x · Cited by 64
Stoichiometry and Pharmacology of Two Human α4β2 Nicotinic Receptor Types
Moroni, M., & Bermúdez, I. (2006) · Journal of Molecular Neuroscience · doi:10.1385/jmn:30:1:95 · Cited by 62
Structural determinants of α4β2 nicotinic acetylcholine receptor trafficking
Ren, X.-Q., Cheng, S.-B., Treuil, M. W., Mukherjee, J., Rao, J., Braunewell, K. H., Lindstrom, J. M., & Anand, R. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1079-05.2005 · Cited by 61
Self-citation
Metadata
- Authors
- Nelson, M. E., Kuryatov, A., Choi, C. H., Zhou, Y., & Lindstrom, J.
- Affiliations
- University of Pennsylvania (US)
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 2003-02
- Volume
- 63
- Issue
- 2
- Pages
- 332-341
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W2337946333
- Semantic Scholar
- dbb214d9298a2934b4b744d775aff014dcfae0be
- Cited by
- 422
- References
- 45
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 9 · 2023: 8 · 2022: 10 · 2021: 14 · 2020: 18 · 2019: 8 · 2018: 10 · 2017: 16 · 2016: 23 · 2015: 29 · 2014: 28 · 2013: 23 · 2012: 31
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Molecular Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (R01NS011323)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- nicotinic acetylcholine receptors, subunit stoichiometry, acetylcholine sensitivity, nicotine, receptor maturation, transient transfection, temperature effects, human embryonic kidney cells
- MeSH terms
- Cells, Cultured, Humans, Receptors, Nicotinic, Temperature, Transfection, DNA, Complementary, Cholinergic Agonists, Protein Subunits
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
